ライフサイエンスコーパス: chart

1 logarithm of the minimum angle of resolution chart).

2 CI 3.47-6.34, p < 0.001 for the Intergrowth chart).

3 atal mortality in small infants (29% for all charts).

4 7 were reviewed through electronic and paper chart.

5 range of the classic Coffee Brewing Control Chart.

6 0.15 logMAR, at least 2 lines of the Snellen chart.

7 al acuity assessment by LogMAR "E" screening chart.

8 s to review limited, salient portions of the chart.

9 assessment of visual acuity, the Snellen eye chart.

10 sion, written materials, pedometer, and step chart.

11 d treatment data (surfaces treated) from the chart.

12 ting equivalent GWG at term from the z score charts.

13 ted using recent national or European growth charts.

14 ed defects were selected from a total of 641 charts.

15 at each visit with logarithmic visual acuity charts.

16 ires and from pharmacy printouts and medical charts.

17 ulation, customised, and Intergrowth centile charts.

18 were used to construct multivariate control charts.

19 Data were extracted from patient charts.

20 her than those of the corresponding standard charts.

21 d by the BMI-for-age based on the WHO growth charts.

22 for the graphical display in the form of pie charts.

23 tative of the data than the UK1990 reference charts.

24 tistics were performed, and time series were charted.

25 classes of materials, however, is yet to be charted.

26 To chart a new future for open publishing, we must consider

27 We chart a partial map of brain regions that may be relevan

28 t binding modes of aryl iodides, our results chart a path to actively controlling oxidative addition

29 e organization field theory (TOFT), can help chart a path to progress for cancer researchers by expla

30 sensory perception to amputees, which could chart a route ahead for designing a real-time pain react

31 ases-9th and/or 10th Revisions codes, manual chart abstraction informed etiology, functional class, a

32 collection occurred during August 2018, with chart abstraction of live birth and pregnancy informatio

33 reement with the gold standard based on full chart abstraction, pointing towards additional efficienc

34 ed FPR of 10%, different thresholds for each chart achieved similar sensitivity for perinatal mortali

35 he mean differences between GoCheck Kids and chart acuities (0.010) were not significantly different

36 The mean differences between HOTV-ATS and chart acuities (0.084) were significantly different (P <

37 e example is the relationship between letter chart acuity and reading ability, as demonstrated by the

38 Check Kids within 1 line of the HOTV-ATS and chart acuity were 65.3% and 86.7%, respectively.

39 carbohydrate antibody arraying technique, we charted an initial large-scale map describing the glycom

40 acquired from a planar Macbeth ColorChecker chart and was able to distinguish between its 18 constit

41 ensive picture of genetic architecture to be charted and quantified.

42 offers filtering options through interactive charts and by linking disease relevant data sources.

43 Outcomes were abstracted from charts and compared between groups using multivariable l

44 l samples, using similarity indices, control charts and exploratory analysis of multivariate data to

45 Charts and fundus photographs of consecutive patients wi

46 We abstracted medical charts and tested stool samples for 22 pathogens via mul

47 ons, thorough documentation in the patients' charts, and detailed conversations with patients.

48 Treatment Diabetic Retinopathy Study (ETDRS) charts] and macular thickness on optical coherence tomog

49 o conclude; maternal population BP reference charts are higher compared to standard charts (healthy p

50 ard logarithm of Minimum Angle of Resolution chart at 3 meters.

51 Visual acuity was taken using Snellens chart at 6 m.

52 hm of the minimum angle of resolution number chart at a distance of 4 m under standard lighting by tr

53 were obtained from electronic databases and chart audits.

54 sequencing analyses, and cell fate assays to chart basophil and mast cell differentiation at single-c

55 proaches to establish in male mice, a wiring chart between the insula cortex (IC), a major sensory in

56 via interactive visualizations such as line charts, box plots, scatter plots, histograms and volcano

57 CI 7.32-15.77, p < 0.001 for the Intergrowth chart) but similar in the smallest 5% of the population

58 r gene alterations have been comprehensively charted, but the improvement of cancer patient managemen

59 The cultural repertoires of apes have been charted by identifying cultural differences between popu

60 to color vision and that the proposed CIE-IR chart can be used as a classification method unique to t

61 ce visit using EHR audit logs and determined chart closure times and progress note length from second

62 The primary analysis used chart-confirmed cases with adjudicated symptom onset in

63 At the end, a chart correlating the properties of a semiconductor with

64 d a single-centre, retrospective analysis of chart data for all adult patients aged at least 18 years

65 nt studies using an iterative team approach, charting data, collating, summarising and reporting find

66 ard were excluded, thereby ensuring that the charts depict body composition of infants whose birth we

67 Our method, which we have called Cardigan (ChARting DIsease Gene AssociatioNs), uses semi-supervise

68 Kaplan-Meier analyses assessed time to first chart-documented clinical remission (CR) and symptom res

69 racterized by clinical assessment, review of charts, electroencephalographic (EEG) recordings, and pa

70 Run charts evaluated index length of stay (LOS) and 90-day c

71 visit, generate longer notes, and close the chart faster.

72 s after reduction mammaplasties to develop a chart for a personalized written patient informed consen

73 contrast and glare sensitivity (Pelli-Robson chart for photopic and dark adaptometer for mesopic cond

74 Organization standards and the Fenton growth chart for premature infants.

75 For each patient's ICU stay, we searched the chart for terms that indicated that acute respiratory di

76 he risk factors for the personalized patient chart for the most common complications influencing the

77 regnancies only) gestational-age-specific BP charts for all pregnant women (irrespective of ethnicity

78 DBP/SBP of reference charts for all women and for each ethnic group were high

79 rs for Disease Control and Prevention growth charts for children 6-36 months old and according to Nel

80 mpletion through pharmacy fills and reviewed charts for reasons of non-completion, including adverse

81 Levey-Jennings charts for selected antigens provided a pass/fail criter

82 sease methods and then adjudicating clinical charts for significant, suspected infection and severe i

83 s age- and sex-specific population reference charts for sleep duration and efficiency which can help

84 We aimed to obtain reliable reference charts for sleep duration, estimate the prevalence of sl

85 ongitudinal data to create predictive growth charts for weight in preterm infants from birth till dis

86 rom the REGARDS baseline assessment, medical charts from HF-adjudicated hospitalizations, the America

87 d significantly from 0.33 to 0.2, vertical M-charts- from 0.29 to 0.17 during 6 months of the follow-

88 This review charts future perspectives in the field hoping to encour

89 rence charts are higher compared to standard charts (healthy pregnancies) and are influenced by ethni

90 We utilize multi-dimensional scaling, bar charts, heat maps and node-link visualizations to enable

91 ti-Dimensional Experience Sampling (MDES) to chart how cognition changes over time from moments in ti

92 Horizontal M-charts improved significantly from 0.33 to 0.2, vertical

93 aticity (CIE-IR) chart, which mimics the CIE chart, in order to discriminate between different chemic

94 Data extracted from charts included baseline ROP information, visual acuity

95 he label 'PBP1B' under the first bar of each chart incorrectly read 'PBP1A'.

96 D-DSP is a database of retrospective patient chart information integrated with patient survey data (E

97 Using available chart information, physicians classified their moderate-

98 nal Patient Registry, and review of hospital charts, information on pregnancy periods and outcome wer

99 The chart itself can be relevant to an international audienc

100 were spent on the activity of documentation/charting itself.

101 ep learning pipeline that uses all uncurated chart, lab, and output events for prediction of in-hospi

102 We charted longitudinal antibody responses to SARS-CoV-2 in

103 Reference charts may aid early detection of raised blood pressure

104 Efforts to chart neurodevelopmental changes in emotion have been se

105 study provides novel molecular insights and charts new avenues for therapeutic intervention associat

106 We chart NLR architectural diversity, identify new architec

107 c A on 7 September 2018 and reviewed patient charts, obtained environmental samples, and cultured iso

108 A on September 7, 2018 and reviewed patient charts, obtained environmental samples, and cultured iso

109 A complete chart of cis-regulatory elements and their dynamic activ

110 The resultant chart of institutionally encountered most common complic

111 A design chart of the relative pull-off force as function of non-

112 veloping circuits were identified and growth charting of age-related connections was performed to obt

113 his model allows, under certain assumptions, charting of time-resolved differentiation trajectories w

114 Charts of 133 eyes of 130 consecutive patients were iden

115 The charts of 3,013 eyes from 2,019 patients were reviewed.

116 Charts of 535 patients were reviewed, and 12 patients me

117 on, we retrospectively analyzed the data and charts of 920 patients with ACL rupture who received ind

118 Cumulative sum charts of operating time (OT) assessed institutional lea

119 We reviewed charts of patients who survived at least 3 months after

120 We reviewed charts of patients who survived at least 3 months after

121 Retrospective review of clinical charts of patients with a devastating brain injury whose

122 Charts of patients with endophthalmitis were individuall

123 We retrospectively analyzed the charts of patients with INCPH undergoing abdominal surge

124 fraction (LVEF), and then reviewed the donor charts of unused hearts in New York and Vermont (UNOS Re

125 randomized into 3 groups: control, reference chart only, and reference chart with telereminder.

126 rrected visual acuity (BCVA), Amsler test, M-charts, optical coherence tomography (OCT) and microperi

127 alert activation in their electronic medical charts or not.

128 below the 5th birth-weight centile for each chart (OR 4.47, 95% CI 3.30-6.04, p < 0.001 for the popu

129 e, and exportable in a form of heatmap, line-chart, or text, and the results are easy to share, maint

130 % CI 4.22-7.91, p < 0.001 for the customised chart; OR 10.74, 95% CI 7.32-15.77, p < 0.001 for the In

131 % CI 3.85-7.11, p < 0.001 for the customised chart; OR 4.69, 95% CI 3.47-6.34, p < 0.001 for the Inte

132 % CI 3.22-5.86, p < 0.001 for the population chart; OR 5.23, 95% CI 3.85-7.11, p < 0.001 for the cust

133 % CI 3.30-6.04, p < 0.001 for the population chart; OR 5.78, 95% CI 4.22-7.91, p < 0.001 for the cust

134 The authors chart paths forward addressing this knowledge gap using

135 both inertial and accelerated dynamics, and chart perspectives for future research.

136 tools (process maps, fishbone diagrams, run charts, Plan-Do-Study-Act [PDSA] cycles, and action lear

137 In this Perspective, we chart progress in the RNA-targeting CRISPR-Cas (RCas) fi

138 This review charts progress in molecular magnetism from the perspect

139 The new charts provide a single tool for the assessment of body

140 sing population, customised, and Intergrowth charts, respectively.

141 A retrospective chart review (15 sites) investigated UC and CD patients

142 nd 14 seconds per encounter using EHRs, with chart review (33%), documentation (24%), and ordering (1

143 A retrospective institutional chart review (July 2018-March 2020) was performed on con

144 ing follow-up were analysed by retrospective chart review (mean follow-up time 3 years, range 0.25-7.

145 horts of mania lesions derived from clinical chart review (n = 15) and of control lesions (n = 490).

146 ional 65 (30.8%) DUA-IE hospitalizations and chart review an additional 18 (8.5%).

147 l clinical information was collected through chart review and analyzed for clinical utility.

148 ession tube were identified by retrospective chart review and analyzed.

149 t transfusion, 28 of whom were obtained from chart review and the others by prospective observation.

150 cal data on these patients were collected by chart review and were analyzed.

151 Cases meeting inclusion criteria underwent chart review and, when available, independent review of

152 stics, surgical and anaesthetic details, and chart review at discharge were prospectively collected o

153 Data were obtained from retrospective chart review by investigators at each institution.

154 This retrospective chart review compared patients seen in a multicenter ins

155 A detailed chart review demonstrated that the majority of patients

156 Chart review examining visual acuities from patient visi

157 age processing potentially enables automated chart review for identifying patients with distinctive c

158 Chart review found that reasons for discordance were rel

159 Retrospective chart review identified 133 eyes of 130 consecutive pati

160 Detailed donor chart review identified 36 ideal heart donors, 24 (66.7%

161 Retrospective chart review identified patients that underwent DTI reco

162 Retrospective chart review of 1084 consecutive RLDNs performed between

163 A retrospective chart review of 73 horizontal ridge augmentation cases w

164 Retrospective chart review of 80 eyes of 49 uveitis patients aged <=16

165 Through chart review of a subcohort (1137 recipients), we determ

166 Chart review of AGV and BGI surgical outcomes in patient

167 Single academic medical center chart review of all CRMP5 IgG-positive (serum titer, >1:

168 Retrospective chart review of all MIRM patients examined by the depart

169 We performed a retrospective chart review of all patients with confirmed HCV viremia.

170 A retrospective chart review of all pediatric transplant recipients betw

171 A retrospective chart review of clinical and laboratory data on 39 patie

172 Retrospective chart review of consecutive patients who underwent PPV a

173 This is a retrospective chart review of LC patients treated at Johns Hopkins Hos

174 A retrospective chart review of patients diagnosed with endogenous endop

175 Retrospective chart review of patients who underwent implantation of t

176 A retrospective chart review of patients who underwent vitrectomy using

177 Retrospective chart review of patients with endogenous endophthalmitis

178 Retrospective chart review of patients with Knobloch syndrome who pres

179 We conducted a retrospective chart review of pediatric HT recipients who had undergon

180 Retrospective chart review of pediatric patients treated with immunosu

181 We performed a retrospective chart review on 12 patients (5 females; median age at di

182 Chart review on 25 patients positive for HHV-6 by FA-ME

183 ever, the timing is largely dependent on the chart review stage, which typically requires at least 2

184 We conducted a retrospective chart review to identify all employees with LTBI at time

185 ctober 2016 through October 2017 underwent a chart review to measure the recurrence of or conversion

186 his end, we implemented a systematic medical chart review to obtain more detailed information on addi

187 of death were classified through a detailed chart review using definitions from the Academic Researc

188 A retrospective chart review was conducted comprising all patients who s

189 A retrospective chart review was conducted of all cases of cataract extr

190 A chart review was conducted of patients in whom chronic o

191 A retrospective chart review was conducted on patients with a T2Candida

192 A chart review was performed in a total of 418 adult patie

193 A retrospective chart review was performed of the initial 40 patients wh

194 A chart review was performed on initial average risk scree

195 A retrospective chart review was performed to evaluate 100 consecutive t

196 with PCR (Xpert C. difficile; Cepheid), and chart review was performed.

197 r algorithm (March 1 to April 15, 2020), and chart review was used to validate the diagnosis of asthm

198 for severe sepsis or septic shock on manual chart review were entered into the sepsis registry.

199 Electronic databases and chart review were used for data collection.

200 ecurrence detected by clinical care (through chart review) or self-report, and radiographic recurrenc

201 orical clinical outcomes were ascertained by chart review, and a measure (L(f) ) was used to quantify

202 st, a focused bedside cognitive examination, chart review, and nurse interview.

203 Preeclampsia status was determined by chart review, obstetrician diagnosis, and adjudication b

204 ompleted by referring physicians, electronic chart review, or patient telephone calls.

205 demiologic investigation followed, including chart review, staff interviews, and observations.

206 Through chart review, we characterized macroscopic colitis activ

207 With additional chart review, we identified 6 HCT recipients with BoV de

208 We explored barriers to MOUD uptake using chart review.

209 ined from billing records and confirmed with chart review.

210 -10/31/2020 were analyzed in a retrospective chart review.

211 pilepsy and a normal EEG based on a clinical chart review.

212 nd, if they had persistent symptoms or MG, a chart review.

213 ObservationProcedure: Retrospective chart review.

214 ); 406 (86.0%) were correctly coded based on chart review.

215 ity in prior risk models were ascertained by chart review.

216 ined from billing records and confirmed with chart review.

217 story, and survival data were extracted from chart review.

218 inical effect was evaluated by retrospective chart review.

219 e respiratory distress syndrome criteria via chart review.

220 8)F-DCFPyL PET/CT was recorded from clinical chart review.

221 rveillance, including direct observation and chart review.

222 subjects) with MG; observation procedure(s): chart review; main outcome measures: anatomy, intraocula

223 This study focuses on a retrospective chart-review of neurological examinations and genetic an

224 Of 341 charts reviewed, 251 (74%) patients were eligible for an

225 e visits at facilities with cases to conduct chart reviews and identify possible sources.

226 llected utilizing post-discharge surveys and chart reviews from 5 hospitals (representing 3 hospital

227 We performed chart reviews of common clinical, imaging, and EEG progn

228 Data were pulled via manual, retrospective chart reviews of the electronic medical record.

229 Manual chart reviews to assess fluoroquinolone appropriateness

230 Retrospective chart reviews were performed at participating institutio

231 be determined by questionnaires and hospital chart reviews.

232 ount of bleeding (Pictorial Blood Assessment Chart score; <=2 vs >=3), and randomising centre.

233 correlation of visual acuity compared to the chart screen and a fair correlation of visual acuity com

234 We apply PRISM 4 to chart secondary metabolite biosynthesis in a collection

235 Chart-specific thresholds for the population should be c

236 ment between the ICD code and the documented chart standard for stage of DR and DR-related complicati

237 ch into small subcortical nuclei and help to chart terra incognita.

238 red to the full guideline for graphical flow charts, text, and tables with additional details about t

239 The results are visualized with pie charts that indicate the similarity between spatial regi

240 t potential drug targets, it is essential to chart the architectural features of SARS-CoV-2 and pinpo

241 Here, we use single-cell transcriptomics to chart the cellular landscape of upper and lower airways

242 Focusing primarily on phase 3 studies, we chart the changes in management based on the most releva

243 ion with machine learning, we systematically chart the different layers of metabolic regulation in br

244 using X-ray photoemission spectroscopy, and chart the elemental composition using atom probe tomogra

245 riences during development in a way that can chart the emergence of psychosis in the context of gener

246 ion of heterotrimeric G proteins by RTKs and chart the key steps that mediate such activation.

247 lar activity states across 30 cell types and chart the lung proteome of young and old mice.

248 Here, we chart the origins of Belyaev's foxes in eastern Canada a

249 nderstudied kinases, DeepKinZero can help to chart the phosphoproteome atlas.

250 To chart the regulatory activity underlying these events, w

251 se that single-cell-guided studies will help chart the spatiotemporal molecular and cellular "atlas"

252 We used Seq-Well S(3) to chart the transcriptional landscape of five human inflam

253 In this study, we charted the arcopallial area displaying tectofugal visua

254 fine the neurons with altered expression, we charted the temporal course of molecular changes followi

255 mic, transcriptomic, and epigenomic datasets charting the development of normal human brain with a pa

256 This work charts the phenotypic landscape of ASD-associated genes,

257 In summary, this study charts the proteomic landscape of ALS-related Ubqln2 mut

258 number changes characteristic of cancer and chart their emergence, offering a window into early carc

259 This new approach to charting thylakoid topology lays the foundation for diss

260 Results were visualized in radar charts to assess toxicological response patterns allowin

261 Using neurodevelopmental growth charts to identify a lack of normative development of am

262 ornian births (2007-2012), utilizing z score charts to standardize GWG for gestational duration.

263 Single-cell genomics is essential to chart tumor ecosystems.

264 ox for other tumors, thus paving the way for charting tumor atlases.

265 s and visualization using materials property charts uncover the hidden potential and advantages of dy

266 een March 2012 and January 2016; we reviewed charts up to June 2016.

267 Analogous to normative growth charts used in paediatric medicine for plotting child de

268 -acid coupling transformations, which can be charted using chemoinformatic techniques.

269 report of SPs were validated against patient charts using a structured, retrospective review.

270 representative longitudinal reference growth charts using these methods.

271 reverbal children for comparison with future chart VA outcomes.

272 eight as a function of age, normative models chart variation in clinical cohorts in terms of mappings

273 ts were followed up until they could perform chart visual acuity (VA) testing.

274 n endoscopy environment, consisting of color charts warped inside a rigid tube mimicking a lumen.

275 A Helm Chart was created so that researchers can use Pachyderm

276 Additionally, each subject's chart was reviewed and further abstracted.

277 Seven hundred twenty-five charts were analyzed, and 113 patients met inclusion cri

278 Pareto and percentage run charts were created for baseline and post-intervention d

279 The LMS values underlying the charts were presented, enabling researchers and clinicia

280 Charts were retrospectively reviewed and genetic and cli

281 Clinic charts were retrospectively reviewed for the prior 3.5 y

282 Charts were reviewed for amblyopia treatment, fundus pho

283 es were reviewed for ON invasion assessment, charts were reviewed for basic demographic data.

284 Charts were reviewed for clinical correlations.

285 Charts were reviewed for gestational age, optic nerve ap

286 Charts were reviewed to confirm each patient's diagnosis

287 Individual charts were reviewed to gather clinical information incl

288 Patient charts were reviewed to identify baseline characteristic

289 No individual medical charts were reviewed.

290 Nine hundred eighty-seven charts were reviewed.

291 Patient charts were screened for cataract formation, dry eye, an

292 Population, customised, and Intergrowth charts were studied.

293 gister (EDR Web) and facility-based clinical charts were used to collect variables which were entered

294 tandard deviations from the UK1990 reference charts were used to compute standard deviation scores (S

295 an individual CAR-T cell and simultaneously chart where the CAR-T vector integrates into the genome.

296 I obtained a chart where topics that were commonly in the same itiner

297 lopment of an infrared chromaticity (CIE-IR) chart, which mimics the CIE chart, in order to discrimin

298 Only the reference chart with telereminder group showed a statistically sig

299 control, reference chart only, and reference chart with telereminder.

300 N = 289 and N = 1037 patient charts with linked surveys were included from the US and